naltrexone Tag

Opioid use disorder (OUD) continues to affect millions of people worldwide, making access to effective treatment more important than ever. Among the most extensively studied approaches is medication-assisted treatment (MAT), also known as medications for opioid use disorder (MOUD). MAT combines FDA-approved medications with counseling and behavioral therapies to help individuals manage cravings, reduce withdrawal symptoms, and support long-term recovery. Decades of clinical research have consistently shown that MAT is one of the most effective treatments for opioid use disorder. Rather than replacing one addiction with another — a common misconception — these medications stabilize brain function, allowing individuals to focus on rebuilding their health, relationships, and daily lives. [caption id="attachment_74618" align="aligncenter" width="500"]mat-opioid-use-disorder-pexels Photo by Etatics Inc.[/caption]

MedicalResearch.com Interview with: “Alcohol” by zeevveez is licensed under CC BY 2.0Sarah Dermody PhD Assistant professor School of Psychological Science College of Liberal Art Oregon State University  MedicalResearch.com: What is the background for this study? What are the main findings? Response: Naltrexone is an FDA-approved medication to treat alcohol use disorder. We know that people have difficulty adhering to the prescribed daily medication regimen, and that people who do not adhere to the medication tend not to fair as well in treatment as people who take the medication regularly. This particular study attempted to address the question of why do people with alcohol use disorder have difficulty taking the medication daily? What we found was that people were less likely to take naltrexone after days of heavy drinking or strong alcohol craving versus typical drinking and craving levels. Furthermore, individuals were less likely to take the medication on weekends versus weekdays, which is particularly worrisome because heaviest drinking episodes tend to happen on the weekends.